Submit Deal

DERMIRA INC

Summary

Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 839 M

Avg. Deal Size£ 839 M

Market Context

Senior Management

Tom Wiggans
Chairman and CEO
Erin Murphy
Communications Director

Sort

10 Jan 2020|United States|Pharmaceuticals

Target: DERMIRA INC

Bidder: ELI LILLY AND COMPANY

8 Service Providers

5 Target | 3 Bidder

41 Dealmakers

26 Target | 16 Bidder

£ 838 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy